A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

Completed

Conditions studied: Breast Cancer, Ovarian Cancer, Colorectal Cancer

In brief

The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.

Key facts

Study ID
NCT02517554
Run by
Abramson Cancer Center at Penn Medicine
People needed
120
Starts
2015-08-01
Expected to finish
2019-11-01
Last updated by the study team
2024-01-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.